EML vs. EDEN, PHC, KRPZ, WYN, FAR, BMN, CGH, ARCM, CTL, and KP2
Should you be buying Emmerson stock or one of its competitors? The main competitors of Emmerson include Eden Research (EDEN), Plant Health Care (PHC), Kropz (KRPZ), Wynnstay Group (WYN), Ferro-Alloy Resources (FAR), Bushveld Minerals (BMN), Chaarat Gold (CGH), Arc Minerals (ARCM), CleanTech Lithium (CTL), and Kore Potash (KP2). These companies are all part of the "basic materials" sector.
Emmerson (LON:EML) and Eden Research (LON:EDEN) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.
Emmerson has higher earnings, but lower revenue than Eden Research.
Emmerson has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Eden Research has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500.
Eden Research received 86 more outperform votes than Emmerson when rated by MarketBeat users. Likewise, 64.61% of users gave Eden Research an outperform vote while only 50.88% of users gave Emmerson an outperform vote.
In the previous week, Eden Research had 7 more articles in the media than Emmerson. MarketBeat recorded 7 mentions for Eden Research and 0 mentions for Emmerson. Eden Research's average media sentiment score of 0.26 beat Emmerson's score of 0.00 indicating that Eden Research is being referred to more favorably in the news media.
0.1% of Emmerson shares are owned by institutional investors. Comparatively, 40.2% of Eden Research shares are owned by institutional investors. 11.3% of Emmerson shares are owned by insiders. Comparatively, 12.8% of Eden Research shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Emmerson's return on equity of -15.16% beat Eden Research's return on equity.
Summary
Eden Research beats Emmerson on 7 of the 12 factors compared between the two stocks.
Get Emmerson News Delivered to You Automatically
Sign up to receive the latest news and ratings for EML and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Emmerson Competitors List
Related Companies and Tools
